Gorantla Padmasri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gorantla Padmasri has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Dhaval Shukla
Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
1 shared publication - Dhritiman Chakrabarti
1–4Department of Neuroanesthesia and Neurocritical Care, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India
1 shared publication - Karthik Kulanthaivelu
Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bengaluru, India
1 shared publication - Mathangi Krishnakumar
Department of Anaesthesiology St. John's Medical College Hospital Bengaluru
1 shared publication - Pandarisamy Sundaravadivel
Dept. of Integrative Medical Research PESU IMR,Bengaluru,India
1 shared publication - Pavankumar Katragadda
Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 19 (2) , 208-211
Delayed Presentation of Diencephalic-Mesencephalic Junction Dysplasia With Compulsive Truncal Movements and Blepharospasm: A Case Report From India
Delayed presentation of Diencephalic-Mesencephalic Junction Dysplasia with Compulsive truncal movements and Blepharospasm: A Case Report from India
- 30 April 2026
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 19 (2) , 208-211
Open AccessDelayed Presentation of Diencephalic-Mesencephalic Junction Dysplasia With Compulsive Truncal Movements and Blepharospasm: A Case Report From India
Delayed presentation of Diencephalic-Mesencephalic Junction Dysplasia with Compulsive truncal movements and Blepharospasm: A Case Report from India
- 27 July 2024
- Published by Taylor & Francis in Brain Injury
- Vol. 38 (14) , 1212-1219
The correlation between the severity of paroxysmal sympathetic hyperactivity and plasma catecholamine levels in patients with severe traumatic brain injury
BackgroundThere is limited literature investigating the catecholamine levels in patients with paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury (TBI). The primary objective of this study was to correlate the severity of PSH (assessed using the PSH-Assessment measure [AM]) with plasma catecholamine levels at a resting state.MethodsIn this prospective case-control study, blood samples for epinephrine and norepinephrine estimation were obtained at rest on three consecutive days, only for 'cases' of PSH after severe TBI (s-TBI) and for control patients (matched for age, gender, and Glasgow coma scale [GCS].ResultsTwenty-seven patients with PSH and 16 controls were recruited. The median PSH-AM score was 20 and 9 in cases and controls, respectively. The epinephrine and norepinephrine levels at rest did not correlate with the severity of PSH assessed during PSH paroxysms (p = 0.949 and 0.975). Norepinephrine levels increased in PSH patients over the 3 consecutive days, once PSH was diagnosed (p = 0.022). The length of hospital stay was longer and the motor-GCS score was lower in PSH patients, with no differences in other outcomes between the groups.ConclusionCatecholamine levels in the inter-paroxysmal interval cannot be correlated with PSH severity assessed during the paroxysms. However, the results of the study need to be confirmed by a larger sample size as the study is underpowered.
- 27 July 2024
- Published by Taylor & Francis in Brain Injury
- Vol. 38 (14) , 1212-1219
The correlation between the severity of paroxysmal sympathetic hyperactivity and plasma catecholamine levels in patients with severe traumatic brain injury
BackgroundThere is limited literature investigating the catecholamine levels in patients with paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury (TBI). The primary objective of this study was to correlate the severity of PSH (assessed using the PSH-Assessment measure [AM]) with plasma catecholamine levels at a resting state.MethodsIn this prospective case-control study, blood samples for epinephrine and norepinephrine estimation were obtained at rest on three consecutive days, only for 'cases' of PSH after severe TBI (s-TBI) and for control patients (matched for age, gender, and Glasgow coma scale [GCS].ResultsTwenty-seven patients with PSH and 16 controls were recruited. The median PSH-AM score was 20 and 9 in cases and controls, respectively. The epinephrine and norepinephrine levels at rest did not correlate with the severity of PSH assessed during PSH paroxysms (p = 0.949 and 0.975). Norepinephrine levels increased in PSH patients over the 3 consecutive days, once PSH was diagnosed (p = 0.022). The length of hospital stay was longer and the motor-GCS score was lower in PSH patients, with no differences in other outcomes between the groups.ConclusionCatecholamine levels in the inter-paroxysmal interval cannot be correlated with PSH severity assessed during the paroxysms. However, the results of the study need to be confirmed by a larger sample size as the study is underpowered.